Patent ID: 11944619
Assignee: SRX CARDIO, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 4:
5. The method of claim 1, wherein the compound is selected from:
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N-isopropylpropanamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N-butylpropanamide;
(S)-2-amino-3-(3′-hydroxy-2-methyl-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide;
(2S,3R)-2-amino-3-hydroxy-3-(5-(3-hydroxyphenyl)-4-methylpyridin-2-yl)-N-isopropylpropanamide;
(S)-2-amino-3-(5-(3-hydroxyphenyl)pyridin-2-yl)-N-isopropylpropanamide;
(S)-2-amino-3-(5-(3-hydroxyphenyl)-4-methylpyridin-2-yl)-N-isopropylpropanamide;
(S)-2-amino-3-(2′-fluoro-5′-hydroxy-2-methyl-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide;
(R)-2-amino-N-isopropyl-5-phenyl-2,3-dihydro-1H-indene-2-carboxamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N—((S)-1-(isopropylamino)-1-oxopropan-2-yl)propanamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N—((R)-1-(isopropylamino)-1-oxopropan-2-yl)propanamide;
(R)-2-((S)-3-([1,1′-biphenyl]-4-yl)-2-aminopropanamido)-N-ethyl-3-methylbutanamide;
(S)-2-amino-3-(3′-hydroxy-[1,1′-biphenyl]-4-yl)-N—((S)-1-(isopropylamino)-1-oxopropan-2-yl)propanamide;
(R)-2-amino-5-(3-hydroxyphenyl)-N-isopropyl-6-methyl-2,3-dihydro-1H-indene-2-carboxamide;
(S)-2-amino-3-(3′-hydroxy-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N-cyclopentylpropanamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N—((R)-1-phenylpropan-2-yl)propanamide;
(S)-3-([1,1′-biphenyl]-4-yl)-2-amino-N—((S)-1-phenylpropan-2-yl)propanamide;
(S)-2-amino-3-(2-cyano-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide;
(S)-2-amino-N-isopropyl-3-(2-methoxy-[1,1′-biphenyl]-4-yl)propanamide;
(S)-2-amino-N-isopropyl-3-(2-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)propanamide;
(S)-2-amino-3-(2′,3′-difluoro-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide; and
(S)-2-amino-3-(2-ethyl-[1,1′-biphenyl]-4-yl)-N-isopropylpropanamide;, or a pharmaceutically acceptable salt thereof.